---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-000539"
form_type: "8-K"
ticker: "CADL"
cik: "0001841387"
company_name: "Candel Therapeutics, Inc."
filed_at: "2024-01-03T23:59:59+00:00"
generated_at: "2026-06-07T04:49:22.258906+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Candel Therapeutics regains Nasdaq minimum bid price compliance

## Summary
- Received Nasdaq notice on Dec 28, 2023 that bid price compliance is regained.
- Previously warned on Nov 15, 2023 for closing below $1.00 for 30 consecutive days.
- Nasdaq has closed the matter; no further action required.
- Company's common stock (CADL) continues trading on Nasdaq Global Market.

## SEC filing metadata
- accession: 0000950170-24-000539
- form_type: 8-K
- ticker: CADL
- cik: 0001841387
- company_name: Candel Therapeutics, Inc.
- filed_at: 2024-01-03T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841387/000095017024000539/0000950170-24-000539-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841387/000095017024000539/cadl-20231228.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-000539
- JSON: https://secwatch.observer/filing/0000950170-24-000539.json
- Plain text: https://secwatch.observer/filing/0000950170-24-000539.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.